Skip to main content

and
  1. Article

    Open Access

    Use of CAM among cancer patients

    The use of complementary and alternative medicine (CAM) by patients is widespread. However, there is a lack of knowledge regarding the extent and details of patient CAM use in Sweden, especially in rural Swede...

    Mikael Källman, Stefan Bergström in BMC Complementary Medicine and Therapies (2023)

  2. Article

    Open Access

    Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients

    An important aspect of end-of-life care is the place of death. A majority of cancer patients prefer home death to hospital death. At the same time, the actual location of death is often against patient’s last-...

    Jonas Nilsson, Georg Holgersson, Gustav Ullenhag, Malin Holmgren in BMC Palliative Care (2021)

  3. Article

    Open Access

    The role of income in brain tumor patients: a descriptive register-based study

    Socioeconomic status (SES) and its association with cancer in general have been thoroughly studied in the last decades. Several studies have shown associations between SES and many types of cancer such as lung...

    Jonas Nilsson, Georg Holgersson, Jacob Järås, Stefan Bergström in Medical Oncology (2018)

  4. No Access

    Article

    A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer

    AXL1717 is an orally bioavailable IGF-1R pathway modulator that has been shown to have anti-tumoral effects. The objectives of the present study were to define maximum tolerated dose and the recommended phase...

    Georg Holgersson, Stefan Bergström, Johan Harmenberg, Magnus Ringbom in Medical Oncology (2015)

  5. No Access

    Article

    The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer

    The prognosis for patients with lung cancer is poor with an average of 5-year overall survival rate of only 10–15 % taking all clinical stages together. The aim of this study was to elucidate the impact of the...

    Georg Holgersson, Michael Bergqvist, Jan Nyman, Even Hoye in Medical Oncology (2012)

  6. No Access

    Article

    Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer

    There is a need to improve the prognostic and predictive indicators in non-small cell lung cancer (NSCLC). At present, the main focus is on genetic predictive markers while the prognostic value of the standard...

    Georg Holgersson, Martin Sandelin, Even Hoye, Stefan Bergström in Medical Oncology (2012)